FiercePharma2h
‘We cannot stay silent’: Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
Ozempic’s Active Ingredient May Reduce Alcohol Cravings, Study Says
The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use ...
Nature21h
Dozens of new obesity drugs are coming: these are the ones to watch
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
India TV14d
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
Novo Nordisk recently published favorable results from the FLOW renal outcomes trial, which found that Ozempic (semaglutide) 1.0 mg lowered the risk of kidney disease progression and kidney and ...
Business Wire14d
NVO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Novo Nordisk ... 2.4 mg and 70.2% with semaglutide 2.4 mg.” On this news, the price of Novo Nordisk stock fell nearly 18%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private ...
ABC7 San Francisco14d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also ...
WLKY14d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
12;40;44;06 THESE MEDICATIONS MIMIC THAT NATURAL PROCESS ... drugmaker Novo Nordisk said Tuesday. A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced ...